Inhibition of platelet glycoprotein Ib and its Antithrombotic potential

被引:38
作者
Vanhoorelbeke, Karen [1 ]
Ulrichts, Hans [1 ]
Van de Walle, Gerlinde [1 ]
Fontayne, Alexandre [1 ]
Deckmyn, Hans [1 ]
机构
[1] Katholieke Univ Leuven, IRC, Lab Thrombosis Res, B-8500 Kortrijk, Belgium
关键词
glycoprotein Ib; platelets; antithrombotic agents;
D O I
10.2174/138161207781662867
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The platelet receptor glycoprotein (GP)Ib-IX-V complex plays a dominant role in the first steps of platelet adhesion and arterial thrombus formation. Through its interaction with the multimeric plasma protein von. Willebrand factor (VWF), which is bound to the damaged subendothelial structures, GPIb-IX-V tethers the platelets from the flowing blood thereby slowing them down. This step is a prerequisite for the collagen receptors to participate in firm adhesion resulting in the formation of a first platelet layer which is the basis for further thrombus formation. Recently, other ligands for GPIb-IX-V besides the extensively studied VWF have been identified, such as : a-thrombin, coagulation factor XII (FXII), high molecular weight kininogen (HMWK), factor XI (FXI), integrin Mac-I and P-selectin. In this review, the interaction of GPIb-IX-V with its different ligands is described and the anticipated or demonstrated in vivo effects are discussed.
引用
收藏
页码:2684 / 2697
页数:14
相关论文
共 194 条
[21]   IDENTIFICATION OF ASPARTIC ACID-514 THROUGH GLUTAMIC ACID-542 AS A GLYCOPROTEIN-IB-IX COMPLEX RECEPTOR RECOGNITION SEQUENCE IN VONWILLEBRAND-FACTOR - MECHANISM OF MODULATION OF VONWILLEBRAND-FACTOR BY RISTOCETIN AND BOTROCETIN [J].
BERNDT, MC ;
WARD, CM ;
BOOTH, WJ ;
CASTALDI, PA ;
MAZUROV, AV ;
ANDREWS, RK .
BIOCHEMISTRY, 1992, 31 (45) :11144-11151
[22]  
Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178
[23]   The adhesion molecule P-selectin and cardiovascular disease [J].
Blann, AD ;
Nadar, SK ;
Lip, GYH .
EUROPEAN HEART JOURNAL, 2003, 24 (24) :2166-2179
[24]   THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT [J].
BODE, W ;
MAYR, I ;
BAUMANN, U ;
HUBER, R ;
STONE, SR ;
HOFSTEENGE, J .
EMBO JOURNAL, 1989, 8 (11) :3467-3475
[25]  
BODE W, 1992, PROTEIN SCI, V1, P426
[26]   The cytoplasmic domain of the platelet glycoprotein Ibα is phosphorylated at Serine 609 [J].
Bodnar, RJ ;
Gu, MY ;
Li, ZY ;
Englund, GD ;
Du, XP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33474-33479
[27]   INHERITANCE AND BLEEDING IN FACTOR-XI DEFICIENCY [J].
BOLTONMAGGS, PHB ;
WANYIN, BY ;
MCCRAW, AH ;
SLACK, J ;
KERNOFF, PBA .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (04) :521-528
[28]   Adhesion of activated platelets to endothelial cells:: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), αvβ3 integrin, and GPIbα [J].
Bombeli, T ;
Schwartz, BR ;
Harlan, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (03) :329-339
[29]   Shielding the front-strand β3 of the !von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibα [J].
Bonnefoy, A ;
Yamamoto, H ;
Thys, C ;
Kito, M ;
Vermylen, J ;
Hoylaerts, MF .
BLOOD, 2003, 101 (04) :1375-1383
[30]   Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation [J].
Bradford, HN ;
Pixley, RA ;
Colman, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :22756-22763